Home
RYTM
RYTM News

Latest Rhythm Pharmaceuticals Inc. (RYTM) News on July 26, 2024

MT Newswires

a day ago

Needham Adjusts Price Target on Rhythm Pharmaceuticals to $55 From $46, Maintains Buy Rating

MT Newswires

3 days ago

Rhythm Pharmaceuticals Doses First Patients in Trial of Hypothalamic Obesity Treatment

Rhythm Pharmaceuticals Announces First Patients Dosed in Phase 2 Trial Evaluating Oral MC4R Agonist LB54640 in Hypothalamic Obesity

GlobeNewswire

3 days ago

Rhythm Pharmaceuticals Announces First Patients Dosed in Phase 2 Trial Evaluating Oral MC4R Agonist LB54640 in Hypothalamic Obesity

Rhythm Pharmaceuticals to Report Second Quarter 2024 Financial Results on Tuesday, August 6, 2024

GlobeNewswire

4 days ago

Rhythm Pharmaceuticals to Report Second Quarter 2024 Financial Results on Tuesday, August 6, 2024

MT Newswires

8 days ago

Rhythm Pharmaceuticals Insider Sold Shares Worth $554,817, According to a Recent SEC Filing

Rhythm Pharmaceuticals Announces New Employment Inducement Grants

GlobeNewswire

15 days ago

Rhythm Pharmaceuticals Announces New Employment Inducement Grants

MT Newswires

18 days ago

Rhythm Pharmaceuticals Appoints Alastair Garfield as Chief Scientific Officer

Rhythm Pharmaceuticals Announces Appointment of Alastair Garfield, Ph.D., as Chief Scientific Officer

GlobeNewswire

18 days ago

Rhythm Pharmaceuticals Announces Appointment of Alastair Garfield, Ph.D., as Chief Scientific Officer

MT Newswires

a month ago

Rhythm Pharmaceuticals Says EMA Committee Backs Expanded Authorization for Obesity Drug

Rhythm Pharmaceuticals Receives Positive CHMP Opinion for ▼IMCIVREE® (setmelanotide) for the Treatment of Obesity and Control of Hunger in Patients between 2 and 6 years old with Bardet Biedl Syndrome or POMC, PCSK1, or LEPR Deficiency

GlobeNewswire

a month ago

Rhythm Pharmaceuticals Receives Positive CHMP Opinion for ▼IMCIVREE® (setmelanotide) for the Treatment of Obesity and Control of Hunger in Patients between 2 and 6 years old with Bardet Biedl Syndrome or POMC, PCSK1, or LEPR Deficiency

Rhythm Pharmaceuticals Announces New Employment Inducement Grants

GlobeNewswire

a month ago

Rhythm Pharmaceuticals Announces New Employment Inducement Grants

Rhythm Pharmaceuticals Presents Patient-reported Experiences with Hyperphagia in Hypothalamic Obesity at ENDO 2024

GlobeNewswire

2 months ago

Rhythm Pharmaceuticals Presents Patient-reported Experiences with Hyperphagia in Hypothalamic Obesity at ENDO 2024

Rhythm Pharmaceuticals Announces Participation at Upcoming Investor Conference

GlobeNewswire

2 months ago

Rhythm Pharmaceuticals Announces Participation at Upcoming Investor Conference

While Rhythm Pharmaceuticals (NASDAQ:RYTM) shareholders have made 125% in 1 year, increasing losses might now be front of mind as stock sheds 3.2% this week

Simply Wall St.

2 months ago

While Rhythm Pharmaceuticals (NASDAQ:RYTM) shareholders have made 125% in 1 year, increasing losses might now be front of mind as stock sheds 3.2% this week

MT Newswires

2 months ago

Rhythm Pharmaceuticals' Imcivree Gains UK Recommendation for Treating Bardet-Biedl Syndrome

Rhythm Pharmaceuticals Receives Positive Recommendation from NICE for ▼IMCIVREE® (setmelanotide) for Treatment of Obesity and Hyperphagia in Patients with Bardet-Biedl Syndrome

GlobeNewswire

2 months ago

Rhythm Pharmaceuticals Receives Positive Recommendation from NICE for ▼IMCIVREE® (setmelanotide) for Treatment of Obesity and Hyperphagia in Patients with Bardet-Biedl Syndrome

Rhythm Pharmaceuticals Announces New Employment Inducement Grants

GlobeNewswire

3 months ago

Rhythm Pharmaceuticals Announces New Employment Inducement Grants

Rhythm Pharmaceuticals, Inc. (NASDAQ:RYTM) Q1 2024 Earnings Call Transcript

Insider Monkey

3 months ago

Rhythm Pharmaceuticals, Inc. (NASDAQ:RYTM) Q1 2024 Earnings Call Transcript

GuruFocus.com

3 months ago

Rhythm Pharmaceuticals Inc (RYTM) Q1 2024 Earnings Call Transcript Highlights: A Detailed ...

Thomson Reuters StreetEvents

3 months ago

Q1 2024 Rhythm Pharmaceuticals Inc Earnings Call

MT Newswires

3 months ago

Rhythm Pharmaceuticals' Q1 Net Loss Widens as Revenue Increases; Shares Fall Pre-Bell

GuruFocus.com

3 months ago

Rhythm Pharmaceuticals Reports Q1 2024 Results: Revenue Growth Amidst Challenges

Rhythm Pharmaceuticals, Inc. (RYTM) Reports Q1 Loss, Misses Revenue Estimates

Zacks

3 months ago

Rhythm Pharmaceuticals, Inc. (RYTM) Reports Q1 Loss, Misses Revenue Estimates

Rhythm Pharmaceuticals Reports First Quarter 2024 Financial Results and Business Update

GlobeNewswire

3 months ago

Rhythm Pharmaceuticals Reports First Quarter 2024 Financial Results and Business Update

Rhythm Pharmaceuticals Presents Data from Phase 3 Pediatrics Trial at Pediatric Endocrine Society Annual Meeting

GlobeNewswire

3 months ago

Rhythm Pharmaceuticals Presents Data from Phase 3 Pediatrics Trial at Pediatric Endocrine Society Annual Meeting

Will Amicus Therapeutics (FOLD) Report Negative Q1 Earnings? What You Should Know

Zacks

3 months ago

Will Amicus Therapeutics (FOLD) Report Negative Q1 Earnings? What You Should Know

Earnings Preview: Rhythm Pharmaceuticals, Inc. (RYTM) Q1 Earnings Expected to Decline

Zacks

3 months ago

Earnings Preview: Rhythm Pharmaceuticals, Inc. (RYTM) Q1 Earnings Expected to Decline

Rhythm Pharmaceuticals Announces Publication of Results from Phase 2 Study of Setmelanotide for the Treatment of Hypothalamic Obesity in The Lancet Diabetes & Endocrinology

GlobeNewswire

3 months ago

Rhythm Pharmaceuticals Announces Publication of Results from Phase 2 Study of Setmelanotide for the Treatment of Hypothalamic Obesity in The Lancet Diabetes & Endocrinology

Rhythm Pharmaceuticals to Report First Quarter 2024 Financial Results on Tuesday, May 7, 2024

GlobeNewswire

3 months ago

Rhythm Pharmaceuticals to Report First Quarter 2024 Financial Results on Tuesday, May 7, 2024

Rhythm Pharmaceuticals Announces New Employment Inducement Grants

GlobeNewswire

3 months ago

Rhythm Pharmaceuticals Announces New Employment Inducement Grants

Market Sentiment Around Loss-Making Rhythm Pharmaceuticals, Inc. (NASDAQ:RYTM)

Simply Wall St.

3 months ago

Market Sentiment Around Loss-Making Rhythm Pharmaceuticals, Inc. (NASDAQ:RYTM)

Moderna (MRNA) Surges 6.2%: Is This an Indication of Further Gains?

Zacks

4 months ago

Moderna (MRNA) Surges 6.2%: Is This an Indication of Further Gains?

Rhythm Pharmaceuticals Secures $150 Million in Convertible Preferred Stock Financing

GlobeNewswire

4 months ago

Rhythm Pharmaceuticals Secures $150 Million in Convertible Preferred Stock Financing

Rhythm Pharmaceuticals Announces First Patient Dosed in Phase 1 Trial Evaluating RM-718, a Weekly MC4R-specific Agonist

GlobeNewswire

4 months ago

Rhythm Pharmaceuticals Announces First Patient Dosed in Phase 1 Trial Evaluating RM-718, a Weekly MC4R-specific Agonist

Chief Technical Officer Joseph Shulman Sells 18,235 Shares of Rhythm Pharmaceuticals Inc (RYTM)

GuruFocus.com

4 months ago

Chief Technical Officer Joseph Shulman Sells 18,235 Shares of Rhythm Pharmaceuticals Inc (RYTM)

Insider Sell: Rhythm Pharmaceuticals Inc (RYTM) CEO David Meeker Disposes of 45,494 Shares

GuruFocus.com

4 months ago

Insider Sell: Rhythm Pharmaceuticals Inc (RYTM) CEO David Meeker Disposes of 45,494 Shares

Insider Sell: Chief Technical Officer Joseph Shulman Sells 15,515 Shares of Rhythm ...

GuruFocus.com

4 months ago

Insider Sell: Chief Technical Officer Joseph Shulman Sells 15,515 Shares of Rhythm ...

Insider Sell: CFO Hunter Smith Sells 15,515 Shares of Rhythm Pharmaceuticals Inc (RYTM)

GuruFocus.com

4 months ago

Insider Sell: CFO Hunter Smith Sells 15,515 Shares of Rhythm Pharmaceuticals Inc (RYTM)

Rhythm Pharmaceuticals Announces New Employment Inducement Grants

GlobeNewswire

5 months ago

Rhythm Pharmaceuticals Announces New Employment Inducement Grants

Rhythm Pharmaceuticals Announces Participation at Upcoming Investor Conferences

GlobeNewswire

5 months ago

Rhythm Pharmaceuticals Announces Participation at Upcoming Investor Conferences

Rhythm Pharmaceuticals Full Year 2023 Earnings: Revenues Disappoint

Simply Wall St.

5 months ago

Rhythm Pharmaceuticals Full Year 2023 Earnings: Revenues Disappoint

Rhythm Pharmaceuticals, Inc. (NASDAQ:RYTM) Consensus Forecasts Have Become A Little Darker Since Its Latest Report

Simply Wall St.

5 months ago

Rhythm Pharmaceuticals, Inc. (NASDAQ:RYTM) Consensus Forecasts Have Become A Little Darker Since Its Latest Report

Rhythm Pharmaceuticals, Inc. (NASDAQ:RYTM) Q4 2023 Earnings Call Transcript

Insider Monkey

5 months ago

Rhythm Pharmaceuticals, Inc. (NASDAQ:RYTM) Q4 2023 Earnings Call Transcript

Thomson Reuters StreetEvents

5 months ago

Q4 2023 Rhythm Pharmaceuticals Inc Earnings Call

Rhythm Pharmaceuticals, Inc. (RYTM) Reports Q4 Loss, Misses Revenue Estimates

Zacks

5 months ago

Rhythm Pharmaceuticals, Inc. (RYTM) Reports Q4 Loss, Misses Revenue Estimates

GuruFocus.com

5 months ago

Rhythm Pharmaceuticals Inc (RYTM) Reports Q4 and Full Year 2023 Financial Results

Rhythm Pharmaceuticals Announces Clinical Development Plan of Setmelanotide for Hypothalamic Obesity in Japan

GlobeNewswire

5 months ago

Rhythm Pharmaceuticals Announces Clinical Development Plan of Setmelanotide for Hypothalamic Obesity in Japan

Rhythm Pharmaceuticals Reports Fourth Quarter 2023 Financial Results and Business Update

GlobeNewswire

5 months ago

Rhythm Pharmaceuticals Reports Fourth Quarter 2023 Financial Results and Business Update

Earnings Preview: ADC Therapeutics SA (ADCT) Q4 Earnings Expected to Decline

Zacks

5 months ago

Earnings Preview: ADC Therapeutics SA (ADCT) Q4 Earnings Expected to Decline

Chief Technical Officer Joseph Shulman Sells Shares of Rhythm Pharmaceuticals Inc

GuruFocus.com

5 months ago

Chief Technical Officer Joseph Shulman Sells Shares of Rhythm Pharmaceuticals Inc

Rhythm Pharmaceuticals, Inc. (RYTM) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release

Zacks

5 months ago

Rhythm Pharmaceuticals, Inc. (RYTM) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release

EVP Yann Mazabraud Sells 2,551 Shares of Rhythm Pharmaceuticals Inc

GuruFocus.com

5 months ago

EVP Yann Mazabraud Sells 2,551 Shares of Rhythm Pharmaceuticals Inc

PRIMECAP Management Reduces Stake in Rhythm Pharmaceuticals

GuruFocus.com

5 months ago

PRIMECAP Management Reduces Stake in Rhythm Pharmaceuticals

Strength Seen in Puma Biotech (PBYI): Can Its 10.0% Jump Turn into More Strength?

Zacks

5 months ago

Strength Seen in Puma Biotech (PBYI): Can Its 10.0% Jump Turn into More Strength?

Rhythm Pharmaceuticals Announces New Employment Inducement Grants

GlobeNewswire

6 months ago

Rhythm Pharmaceuticals Announces New Employment Inducement Grants

Rhythm Pharmaceuticals Announces Positive Reimbursement Decision in Italy for IMCIVREE® (setmelanotide) for the Treatment of Obesity and Control of Hunger in Bardet-Biedl Syndrome

GlobeNewswire

6 months ago

Rhythm Pharmaceuticals Announces Positive Reimbursement Decision in Italy for IMCIVREE® (setmelanotide) for the Treatment of Obesity and Control of Hunger in Bardet-Biedl Syndrome

Modine (MOD) is on the Move, Here's Why the Trend Could be Sustainable

Zacks

6 months ago

Modine (MOD) is on the Move, Here's Why the Trend Could be Sustainable

Kulicke and Soffa (KLIC) Beats Q1 Earnings and Revenue Estimates

Zacks

6 months ago

Kulicke and Soffa (KLIC) Beats Q1 Earnings and Revenue Estimates

Rhythm Pharmaceuticals to Report Fourth Quarter and Full Year 2023 Financial Results on Thursday, February 22, 2024

GlobeNewswire

6 months ago

Rhythm Pharmaceuticals to Report Fourth Quarter and Full Year 2023 Financial Results on Thursday, February 22, 2024

Vaxcyte Announces Commencement of Proposed Public Offering of Common Stock and Pre-Funded Warrants

GlobeNewswire

6 months ago

Vaxcyte Announces Commencement of Proposed Public Offering of Common Stock and Pre-Funded Warrants

Co-founders of AllianceBernstein's Autonomous research quit ahead of SocGen venture

Reuters

6 months ago

Co-founders of AllianceBernstein's Autonomous research quit ahead of SocGen venture

Carpenter Technology (CRS) Q2 Earnings Match Estimates

Zacks

6 months ago

Carpenter Technology (CRS) Q2 Earnings Match Estimates

3 No-Brainer Stocks to Buy Before a Bull Run

Motley Fool

6 months ago

3 No-Brainer Stocks to Buy Before a Bull Run

Western Union to Release Fourth Quarter and Full Year 2023 Results on February 6

Business Wire

6 months ago

Western Union to Release Fourth Quarter and Full Year 2023 Results on February 6

3 Stocks to Sell as the Cryptocurrency Craze Fades

InvestorPlace

6 months ago

3 Stocks to Sell as the Cryptocurrency Craze Fades

IPO Stock Of The Week: Cloud Software Leader Intapp Hits Early Buy Point

Investor's Business Daily

6 months ago

IPO Stock Of The Week: Cloud Software Leader Intapp Hits Early Buy Point

Is Leggett & Platt (LEG) Stock Undervalued Right Now?

Zacks

6 months ago

Is Leggett & Platt (LEG) Stock Undervalued Right Now?

RLX Technology Unveils 2022-2023 Corporate Social Responsibility Report

PR Newswire

6 months ago

RLX Technology Unveils 2022-2023 Corporate Social Responsibility Report

Penumbra (PEN) Rides on Vascular Arm Strength Amid FX Woes

Zacks

6 months ago

Penumbra (PEN) Rides on Vascular Arm Strength Amid FX Woes

Ziff Davis to Participate in One Investor Conference in February

Business Wire

6 months ago

Ziff Davis to Participate in One Investor Conference in February

Insider Sell: ExecChairman & Chief Bus Dev Marc Zandman Sells 14,846 Shares of Vishay ...

GuruFocus.com

6 months ago

Insider Sell: ExecChairman & Chief Bus Dev Marc Zandman Sells 14,846 Shares of Vishay ...

Leggett (LEG) Unveils Restructuring Plan, Withdraws Targets

Zacks

6 months ago

Leggett (LEG) Unveils Restructuring Plan, Withdraws Targets

Analysts Estimate Cathay General (CATY) to Report a Decline in Earnings: What to Look Out for

Zacks

6 months ago

Analysts Estimate Cathay General (CATY) to Report a Decline in Earnings: What to Look Out for

Ditch Your Resolutions Day is Here - Life Time Experts Share Tips to Ensure Your Goals Stick

PR Newswire

6 months ago

Ditch Your Resolutions Day is Here - Life Time Experts Share Tips to Ensure Your Goals Stick

Vertex Withdraws Offer to Acquire Pagero

GlobeNewswire

6 months ago

Vertex Withdraws Offer to Acquire Pagero

Rhythm Pharmaceuticals Announces New Employment Inducement Grants

GlobeNewswire

6 months ago

Rhythm Pharmaceuticals Announces New Employment Inducement Grants

First Interstate BancSystem, Inc. Announces Fourth Quarter Earnings Release and Conference Call

Business Wire

6 months ago

First Interstate BancSystem, Inc. Announces Fourth Quarter Earnings Release and Conference Call

Better Than BTC: 7 Crypto Stocks With the Potential to Outperform Bitcoin

InvestorPlace

6 months ago

Better Than BTC: 7 Crypto Stocks With the Potential to Outperform Bitcoin

Summit's (SUM) Shareholders Approve Merger With Argos USA

Zacks

6 months ago

Summit's (SUM) Shareholders Approve Merger With Argos USA

3 Crypto Investments That Dwarfed Shiba Inu in 2023

Motley Fool

6 months ago

3 Crypto Investments That Dwarfed Shiba Inu in 2023

Growth Stocks on the Brink: 7 Picks Poised for Explosive Returns

InvestorPlace

6 months ago

Growth Stocks on the Brink: 7 Picks Poised for Explosive Returns

Alight named a Leader in Everest Group’s Global Multi-Country Payroll (MCP) Solutions PEAK Matrix® 2023

Business Wire

6 months ago

Alight named a Leader in Everest Group’s Global Multi-Country Payroll (MCP) Solutions PEAK Matrix® 2023

Gates Industrial to Host Capital Markets Day on March 11, 2024

PR Newswire

7 months ago

Gates Industrial to Host Capital Markets Day on March 11, 2024

COPT Defense Provides Conference Call Details to Discuss 4Q and YE 2023 Results and Management’s 2024 Outlook

Business Wire

7 months ago

COPT Defense Provides Conference Call Details to Discuss 4Q and YE 2023 Results and Management’s 2024 Outlook

Avient To Hold Fourth Quarter 2023 Conference Call

PR Newswire

7 months ago

Avient To Hold Fourth Quarter 2023 Conference Call

HashiCorp appoints Michael Weingartner as Chief Product Officer, promotes Talha Tariq to Chief Information Officer and Chief Security Officer

GlobeNewswire

7 months ago

HashiCorp appoints Michael Weingartner as Chief Product Officer, promotes Talha Tariq to Chief Information Officer and Chief Security Officer

DigitalBridge Strengthens Commitment to European Region with Hiring of Ersin Yorulmaz as Co-Head of European Capital Formation

Business Wire

7 months ago

DigitalBridge Strengthens Commitment to European Region with Hiring of Ersin Yorulmaz as Co-Head of European Capital Formation

Xenon Pharmaceuticals Outlines Key Milestone Opportunities for 2024

GlobeNewswire

7 months ago

Xenon Pharmaceuticals Outlines Key Milestone Opportunities for 2024

Agilon Health Stocks Sinks 35%. It Slashes Margin Guidance on Higher Medical Costs.

Barrons.com

7 months ago

Agilon Health Stocks Sinks 35%. It Slashes Margin Guidance on Higher Medical Costs.

Select Medical (SEM) Unveils Separation Plan for Concentra

Zacks

7 months ago

Select Medical (SEM) Unveils Separation Plan for Concentra

Why Select Medical (SEM) is a Top Momentum Stock for the Long-Term

Zacks

7 months ago

Why Select Medical (SEM) is a Top Momentum Stock for the Long-Term

LG Display (LPL) to Introduce 480Hz QHD Gaming OLED Screens

Zacks

7 months ago

LG Display (LPL) to Introduce 480Hz QHD Gaming OLED Screens

Rhythm Pharmaceuticals and LG Chem Life Sciences Enter Agreement for Rhythm to Acquire Global Rights to Oral MC4R Agonist LB54640

GlobeNewswire

7 months ago

Rhythm Pharmaceuticals and LG Chem Life Sciences Enter Agreement for Rhythm to Acquire Global Rights to Oral MC4R Agonist LB54640

Rhythm Pharmaceuticals Announces Completion of Screening for Enrollment in Setmelanotide Phase 3 Hypothalamic Obesity Trial and Additional Updates

GlobeNewswire

7 months ago

Rhythm Pharmaceuticals Announces Completion of Screening for Enrollment in Setmelanotide Phase 3 Hypothalamic Obesity Trial and Additional Updates

15 Best Growth Stocks to Buy Under $25

Insider Monkey

7 months ago

15 Best Growth Stocks to Buy Under $25

Is Patterson Companies, Inc.'s (NASDAQ:PDCO) Stock's Recent Performance Being Led By Its Attractive Financial Prospects?

Simply Wall St.

7 months ago

Is Patterson Companies, Inc.'s (NASDAQ:PDCO) Stock's Recent Performance Being Led By Its Attractive Financial Prospects?

Insider Sell: Rhythm Pharmaceuticals CTO Joseph Shulman Sells 12,941 Shares

GuruFocus.com

7 months ago

Insider Sell: Rhythm Pharmaceuticals CTO Joseph Shulman Sells 12,941 Shares

Five9 Stock Belongs On Your Watchlist As RS Rating Jump Higher

Investor's Business Daily

7 months ago

Five9 Stock Belongs On Your Watchlist As RS Rating Jump Higher

Apple Hospitality REIT Publishes Annual Corporate Responsibility Report

Business Wire

7 months ago

Apple Hospitality REIT Publishes Annual Corporate Responsibility Report

Business Wire

7 months ago

Empire State Realty Trust Announces Stock Repurchase Authorization

Share on Social Networks: